Response to cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) poorly responding to docetaxel
| dc.contributor.author | Campos Balea, B. | |
| dc.contributor.author | Oudard, S. | |
| dc.contributor.author | Munarriz, J. | |
| dc.contributor.author | Ardavanis, A. | |
| dc.contributor.author | Stefanou, D. | |
| dc.contributor.author | Angelergues, A. | |
| dc.contributor.author | Bellmunt, J. | |
| dc.contributor.author | Efstathiou, E. | |
| dc.contributor.author | Gonzalez, I. | |
| dc.contributor.author | Gyftaki, R. | |
| dc.contributor.author | Delanoy, N. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Flechon, A. | |
| dc.contributor.author | Guillot, A. | |
| dc.contributor.author | Le Moulec, S. | |
| dc.contributor.author | Castellano, D. | |
| dc.contributor.author | Esteban, E. | |
| dc.date.accessioned | 2021-03-04T08:19:05Z | |
| dc.date.available | 2021-03-04T08:19:05Z | |
| dc.identifier.citation | Angelergues A., Bellmunt J., Efstathiou E., Gonzalez I., Gyftaki R., Delanoy N., Ozguroglu M., Flechon A., Guillot A., Le Moulec S., et al., "Response to cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) poorly responding to docetaxel", European Cancer Congress / 18th Meeting of the European-Cancer-Organization (ECCO) / 40th Meeting of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 25 - 29 Eylül 2015, cilt.51 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_62adb096-176b-45a2-9477-3e40420593a3 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/68721 | |
| dc.identifier.uri | https://doi.org/10.1016/s0959-8049(16)31357-0 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Response to cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) poorly responding to docetaxel | |
| dc.type | Bildiri | |
| dc.contributor.department | Assistance Publique Hopitaux Paris (APHP) , , | |
| dc.identifier.volume | 51 | |
| dc.contributor.firstauthorID | 147765 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]